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Background: Despite significant increases in global health investment and the availability of low-cost, efficacious
interventions to prevent mother-to-child HIV transmission (pMTCT) in low- and middle-income countries with high
HIV burden, the translation of scientific advances into effective delivery strategies has been slow, uneven and
incomplete. As a result, pediatric HIV infection remains largely uncontrolled. A five-step, facility-level systems analysis
and improvement intervention (SAIA) was designed to maximize effectiveness of pMTCT service provision by
improving understanding of inefficiencies (step one: cascade analysis), guiding identification and prioritization of
low-cost workflow modifications (step two: value stream mapping), and iteratively testing and redesigning these
modifications (steps three through five). This protocol describes the SAIA intervention and methods to evaluate the
intervention’s impact on reducing drop-offs along the pMTCT cascade.
Methods: This study employs a two-arm, longitudinal cluster randomized trial design. The unit of randomization is
the health facility. A total of 90 facilities were identified in Côte d’Ivoire, Kenya and Mozambique (30 per country). A
subset was randomly selected and assigned to intervention and comparison arms, stratified by country and service
volume, resulting in 18 intervention and 18 comparison facilities across all three countries, with six intervention and six
comparison facilities per country. The SAIA intervention will be implemented for six months in the 18 intervention
facilities. Primary trial outcomes are designed to assess improvements in the pMTCT service cascade, and include the
percentage of pregnant women being tested for HIV at the first antenatal care visit, the percentage of HIV-infected
pregnant women receiving adequate prophylaxis or combination antiretroviral therapy in pregnancy, and the
percentage of newborns exposed to HIV in pregnancy receiving an HIV diagnosis eight weeks postpartum. The
Consolidated Framework for Implementation Research (CFIR) will guide collection and analysis of qualitative data on
implementation process.
Discussion: This study is a pragmatic trial that has the potential benefit of improving maternal and infant outcomes by
reducing drop-offs along the pMTCT cascade. The SAIA intervention is designed to provide simple tools to guide
decision-making for pMTCT program staff at the facility level, and to identify low cost, contextually appropriate pMTCT
improvement strategies.
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Despite cost-effective, efficacious interventions to prevent
pediatric HIV infection, as well as large investments to
scale-up pMTCT services in countries with the highest
burden of HIV, pediatric HIV infection remains largely
uncontrolled [1]. Efforts to expand pMTCT have led to
gains in the number of facilities with pMTCT services,
reaching 78% of all clinics with ANC in Mozambique [2],
44% in Côte d’Ivoire [3], and 58% in Kenya [4]. Despite
this expansion, gaps along the pMTCT cascade limit its
effectiveness, with low coverage of HIV counseling and
testing in the study countries (reaching between 47% to
72% of estimated HIV-infected women), low maternal
access to ART prophylaxis and triple-therapy for eligible
women (44% to 72% of estimated HIV-infected pregnant
women), and limited infant access to ART prophylaxis
(reaching 33% to 59% of infants born to identified
HIV-infected women in the study countries). Infant
feeding practices, low post-partum use of family planning,
weak linkages with HIV care, and sub-optimal integration
with other effective ANC services further impede pMTCT
effectiveness. As a result, pediatric HIV infection
continues to be common, with mother-to-child HIV
transmission estimated to occur in 24% of children
born to HIV-infected women in Kenya [4], 29% in
Côte d’Ivoire [5], and 27% in Mozambique [6].
Enhancing the implementation of pMTCT interventions
may lead to dramatic improvements in infant and maternal
outcomes through reducing drop-offs along the pMTCT
cascade. However, intervention studies to test novel
implementation approaches for pMTCT have been
limited in scope and methodology, and there are few
published reports that describe large-scale, rigorously
evaluated efforts to improve pMTCT programs in
real-world settings. Operational studies to date have
largely focused on identifying determinants of poor
adherence to care, such as how delays in identification of
infected infants are associated with poor access to
comprehensive HIV care and late initiation of combination
antiretroviral therapy (cART) [7], or how sociodemographic
factors impede pMTCT program participation [8].
Health systems research addressing operational bar-
riers to pMTCT uptake has been largely descriptive,
though has highlighted the importance of health sys-
tems access and systems inefficiencies as factors that
limit the effectiveness of pMTCT services [9]. Further,
studies have identified data management challenges
indicating that inconsistent data flow impede their
use for decision-making and improvement efforts by
pMTCT service management [10]. A further limitation of
the published literature is that operational improvements
have generally been carried out in small pilot programs
[11,12], are mostly hospital based [13], and have short
follow-up periods [14,15].There is a growing recognition that the most critical
priority for improving the effectiveness of pMTCT
services is to increase the number of women successfully
passing through the multiple, sequential steps in the
pMTCT cascade [16], which argues for approaches that
optimize pMTCT system delivery and related HIV care
services in order to increase access to existing, efficacious
interventions. Several novel techniques that have recently
been applied to healthcare settings have the potential to
improve health outcomes by identifying and reducing
system inefficiencies and improving program effectiveness
in complex, multi-step health services, such as the
pMTCT cascade. These tools, such as value stream or
process mapping, and continuous quality improve-
ment, have been adapted from industrial and systems
engineering to improve manufacturing, and have led
to dramatic and rapid increases in program efficiency
through simple, low cost, iterative adaptations in process
design and service delivery [17,18]. A common element
of systems analysis and improvement approaches is to
describe and understand the existing system to identify
problems and risks, and to generate solutions. Process
mapping engages health managers and workers to describe
the discrete, sequential steps in multi-step health service
delivery strategies, which then serve as a basis for
identifying contextually-appropriate systems innovations
to improve system functioning [19].
A hallmark of systems analysis and improvement
approaches is encouraging the participation of frontline
health workers in analyzing their system, as well as
defining, implementing, and evaluating improvement
strategies using simple, locally accessible, and relevant
data. Previous research, including research from resource
limited settings, has found that engaging local health staff
in health systems analysis and identification of adaptations
for systems improvement leads to strategies that are more
appropriate, effective, and sustainable than health systems
analysis interventions that do not involve local staff [18].
By building a shared understanding of how work is really
carried out, process mapping helps to build common
organizational values and goals, which has been found,
along with the involvement of senior management
champions, to be associated with improved health
service delivery and patient-level outcomes at the facility
level [20,21].
To date, the majority of quality improvement method-
ologies based on the experiences from systems engineering
have been implemented in healthcare systems in high
income countries, and despite their widespread use, there
is insufficient evidence that these techniques improve the
quality of individual health provider care [22-25] and/or
institutional performance [26-32]. Experience with these
systems analysis and improvement techniques is limited but
growing in resource-constrained settings [33,34], including
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on the effectiveness of these approaches is anecdotal
or relies on descriptive studies that document changes
in process measures in a small set of intervention facilities
without a counterfactual, and have shown mixed results
in improving utilization and quality of care measures
[18,37-43]. Given the limited evidence on systems analysis
and improvement interventions, despite their potential for
optimizing complex, linked systems like pMTCT, this area
merits further study [44].Goals and objectives
The goal of this study is to strengthen pMTCT programs
in the three study countries by applying and evaluating
systems analysis and improvement approaches, to build
on existing experience with these techniques.
Our primary hypothesis is that identifying modifiable
barriers to completing steps in the pMTCT cascade and
applying locally-defined innovations will lead to measurable
improvements in the performance of pMTCT services over
and above those observed during the same time period in
control facilities. The primary outcomes for this pragmatic
trial focus on the proportion of women and children pairs
successfully progressing through the pMTCT cascade from
HIV screening at first antenatal care (ANC) visit, to
successful receipt of antiretroviral medicines, and
ending with HIV screening in infants. These measures
are sensitive to the systems analysis and improvement
(SAIA) intervention, readily measurable, and represent
steps that are essential for successful prevention of HIV
acquisition in children. Additional qualitative data collec-
tion embedded into the trial is designed to describe inter-
vention characteristics that may influence the success of
the SAIA intervention, the implementation environment,
and the implementation process.Methods
The SAIA intervention entails mentored, iterative applica-
tion of a systems analysis tool and related improvement
approach to provide facility-level pMTCT staff and
managers with a holistic view of their system’s performance,
identify which steps in the pMTCT cascade are the
highest priority for improvement and which bottlenecks
are modifiable, and test contextually appropriate solutions.
By mentoring facility staff to identify and test solutions, it
is expected that this overall analysis and optimization
process will lead to rapid and sustainable improvements
in pMTCT service delivery, quantified using routinely
available indicators. The findings coming from three
diverse countries in sub-Saharan Africa, coupled with
additional implementation process measures, will provide
practical results that are directly applicable to pMTCT
programs in diverse settings.This intervention incorporates systems engineering
techniques that provide a systems view combined with
iterative improvement cycles, which have been designed
to holistically capture complex real-world systems and
improve their functioning. These methodologies are also
intended to be user friendly and simple to apply in order
to engage frontline health workers and facility managers
in the process of identifying bottlenecks and solutions,
and testing sustainable solutions that are within their
scope of control.
The pragmatic study design and analytical approach
represent an appropriate and robust attempt to evaluate
the study intervention. A cluster randomized design is
feasible and efficient, will adequately enable the detection
of improvements in pMTCT performance associated with
a facility-based intervention, and will reduce the risk of
potential confounding related to assignment of health
facilities to receive the intervention. Furthermore, the
inclusion of three diverse countries in sub-Saharan
Africa will improve the relevance and applicability of
trial results in high need countries.
Trial design
This study employs a two-arm, 1:1 cluster randomized trial
design to assess the effectiveness of the SAIA intervention.
The unit of intervention is the health facility. A total of 36
health facilities are part of the trial, including 18 interven-
tion and 18 comparison facilities (six intervention and six
comparison facilities per country).
Study facilities and setting
The SAIA intervention is applied at the facility-level.
Through improved pMTCT services, it aims to improve
outcomes for pregnant and postpartum mothers and
their infants. Study facilities are split evenly by interven-
tion and comparison group across three sub-Saharan
African countries—Côte d’Ivoire, Kenya and Mozambique
(Figure 1). These three countries were chosen to provide
heterogeneous implementation settings in order to generate
evidence on the SAIA intervention across multiple
countries from diverse geographic regions, with different
health sector designs, varying levels of resource investments,
and different patterns of HIV burden.
Côte d’Ivoire
Study facilities are located in three northern regions of
Côte d’Ivoire (Gbêké, Hambôl, Poro-Tchologo-Bagoue)
which had an estimated adult HIV prevalence of 4.4%,
4.4%, and 2.5% respectively in 2011 – 2012 [45]. PMTCT
services in Côte d’Ivoire are provided primarily through
public sector health facilities, as well as some private facil-
ities. In 2011, 734 health facilities actively provided PMTCT
services in Côte d’Ivoire, of which 113 are located in the









Figure 1 Map of the Systems Analysis and Improvement Approach (SAIA) study countries. Intervention and comparison facilities split
equally across the three study countries (six intervention and six comparison facilities per country).
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November 2012.
Kenya
Study facilities were selected from Nairobi city and
Coast province, which had an estimated adult HIV
prevalence of 4.9% and 4.3%, respectively, in 2012 [46].
PMTCT services in Kenya are primarily provided through
public sector and private not-for-private health facilities,
and use a mixed approach that includes the World HealthOrganization’s Option B + strategy in high volume
facilities, with Option B and A in lower volume facilities.
Mozambique
Study facilities were selected from Dondo and Nhamatanda
districts, and Beira City, located along the heavily populated
Beira corridor in Sofala province, Mozambique. Sofala has
an estimated average adult HIV prevalence of 15.5%, which
is higher in densely populated, urban areas [47]. The
Mozambique National Health Service has a broad network
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formal health services in Sofala, providing over 98%
of outpatient services in the province [48]. Utilization
of primary healthcare services, including maternal and
child health services, is high, and an estimated 95% of
women have at least one ANC visit, and 71% deliver in
institutional settings [49]. Since the launch of multiple
HIV prevention, care and treatment strategies between
2002 – 2004, HIV services (including pMTCT) have been
rapidly scaled-up to achieve geographic coverage in an
integrated fashion [50]. The Ministry of Health uses a
mixed approach for pMTCT, including the World Health
Organization’s Option B + in facilities with current cART
capacity, and Option A in the remaining facilities.
Randomization
All public and non-profit health facilities with pMTCT
services in the study region in each country were consid-
ered for inclusion. Facilities were excluded if they were
more than 20 kilometers from a main transport corridor
to ensure frequent contact with the study team. Facilities
were also excluded if an ongoing prospective study orFigure 2 Facility eligibility and randomization. ANC: Antenatal care; KMsimilar systems analysis and enhancement technique
were being implemented, and if facility managers and/or
staff were unwilling to participate in the study. Consent for
inclusion in the trial was sought from facility leadership
after the randomization process.
A total of 90 health facilities providing pMTCT
(30 per country) provided the initial sample frame
for this study (Figure 2). Study leadership from each
country (including the project Principal Investigator)
met in November 2013, in Beira, Mozambique, to define
intervention and comparison groups. After removing facil-
ities that did not meet the eligibility criteria, the remaining
55 facilities were ranked by country according to volume
of first ANC visits. The top 12 facilities were selected in
each country, and split into two groups of six facilities
(upper and lower 50%, according to ANC volume). Three
facilities from each group were assigned to receive the
intervention and three to not receive the intervention in
each country (using the random number generator in
Excel®), totaling six intervention and six comparison
facilities per country (18 intervention and 18 comparison
facilities in total).: Kilometer; PMTCT: prevention of mother-to-child transmission (of HIV).
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The SAIA intervention is a facility-based, five-step, iterative
process designed to guide pMTCT staff and facility-level
managers in understanding and improving their pMTCT
services. The intervention incorporates tools to enable a
systems view of pMTCT performance from ANC through
postpartum care for mother-infant pairs and to discern
modifiable barriers on which to focus improvement
efforts, followed by continuous quality improvement
cycles to guide facility personnel in the identification,
implementation, and rapid evaluation of appropriate
facility-level solutions (Figure 3).
Step one: PMTCT cascade analysis to understand pMTCT
performance, identify and prioritize areas for
improvement
An essential step for systems improvement is to engage
facility-level pMTCT staff and managers in understanding
their system’s performance and using performance data to
identify and prioritize areas for improvement. A pMTCT
cascade analysis tool (PCAT) was developed to provide
this systems view and highlight priority areas to address
within the pMTCT cascade, based on a similar approach
representing the linkage between HIV testing and com-
bination antiretroviral services in Mozambique (Figure 4)
[51]. This Microsoft Excel©-based tool uses routinely
collected facility data to calculate the number and
proportion of women and children flowing throughFigure 3 Five steps of the Systems Analysis and Improvement Approeach step of the pMTCT cascade, broken down into the
flow from ANC through birth, and the subsequent
postpartum period. The PCAT is also automated to calcu-
late the number lost at each step (difference between
those eligible for and those successfully passing through
each step), and to estimate the additional number of
women and exposed infants who would complete all
pMTCT steps if each step were individually improved; this
calculation assumes that drop-offs for all other steps
remain constant and rates of eligibility to pass to next
steps are similar among those who do and do not pass
through each step. As the first step of the SAIA interven-
tion, the cascade analysis tool is used by study personnel
to guide a discussion with facility-level staff to determine
which steps in the pMTCT cascade are likely to have the
largest effect in order to optimize overall pMTCT services.
Step two: process mapping to identify modifiable
bottlenecks at the facility level
To support facility-level staff in identifying specific
bottlenecks in their pMTCT system, study teams will
work with staff from the ANC, maternity, postpartum,
and at-risk child care settings to map the existing flow of
mother-infant pairs across these services (see Figure 5 for
an example of two ANC flow maps from a large, urban
and a smaller, rural facility in central Mozambique).
By working with facility staff to explicitly describe the
sequential, linked processes of care delivery at theirach (SAIA) intervention.
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Figure 4 PMTCT Cascade Analysis Tool (PCAT). Demonstrates
number lost and potential gains per step (if that step improved to
100%, holding the other steps constant) for the ANC➔maternity
(yellow), and postpartum (blue) cascades. ANC: Antental care; cART:
Combination anti-retroviral therapy; dx: Diagnosed; PPO: Prophylaxis.
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highlighted, and health workers and managers are directly
engaged in process improvement efforts. Each interven-
tion facility’s existing pMTCT flow will be described on
paper with input from multiple pMTCT staff, then be
transferred to a computerized version using Microsoft
Visio, and subsequently be discussed with pMTCT staff to
confirm that it accurately represents the care processes in
place and to identify inefficiencies that can be modified
within each step.
Step three: identify, define, and implement
facility-specific workflow adaptations to eliminate
modifiable bottlenecks
The final three steps of the SAIA intervention build off
of continuous quality improvement methodologies. In
step three, the PCAT analysis and process maps will be a
focal point for brainstorming solutions with facility-level
staff, mentored by study assistants trained in the SAIA
intervention (training includes both didactic introduction
to the intervention, and practical application of the tools
during a one-week pilot phase in each country). It is
expected that these solutions will lead to more efficient
progression across the pMTCT cascade through process
flow adaptation and simplification, task restructuring,
service integration, and/or job aid introduction. Workflow
adaptations will be selected based on their potential to
lead to rapid and sustainable improvements in the
targeted step in the pMTCT cascade, and feasibility of
implementation, including being within the sphere of
influence of facility management and pMTCT staff
(Table 1). An implementation plan for the innovation will
be described in writing by facility and study personnel,
including a future state process map that reflects processes
after the modification, to ensure consensus among facility
staff on the contents of the solution, as well as clarity
of operational design and roles and responsibilities among
facility personnel. After identifying and defining the
adaptation to be implemented, facility staff will implement
the proposed changes.
Step four: assess workflow modification effect on pMTCT
cascade
Using routinely reported pMTCT cascade data from the
pMTCT step that was selected for improvement, facility
staff will monitor improvements in relevant indicators
for two to six weeks following the introduction of the
facility-specific workflow adaptation. Monitoring data
will be analyzed visually and using descriptive statistics
after a short time period, relying on improvements in
the absolute increase in the proportion of women or
infants successfully progressing through the step of interest
to capture large, rapid improvements associated with the
introduction of the adaptation.
Figure 5 Example of pMTCT process maps from two facilities in Sofala Mozambique. Legend: Maps are from a medium-sized rural health
center (Tica) and large urban health center (Munhava) in 2009, and demonstrate the flow of women from entry into antental care through receipt
of antiretroviral prophylaxis or combination antiretroviral therapy.
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Table 1 Illustrative facility-level workflow modifications
Intended effect Workflow modification
Increase the proportion of women in ANC who
receive HIV testing and counseling
Initiate a grouped HIV counseling protocol for pregnant women in the ANC service waiting
area rather than providing individual counseling for all women within ANC services.
Increase the proportion of HIV-infected pregnant
women with access to CD4 testing
Initiate CD4 blood draw for HIV-infected women by ANC nurses at the time of HIV diagnosis
rather than referral to separate HIV clinics for enrolment and subsequent blood draw.
Increase the proportion of eligible HIV-infected pregnant
women who initiate cART during pregnancy
Initiate cART for eligible pregnant women after the first counseling visit post determination
of eligibility rather than requiring completion of three counseling visits before initiating
cART (while maintaining subsequent counseling visits post-cART initiation).
Increase the proportion of HIV-exposed infants receiving
HIV screening with PCR at six weeks of age
Attach ANC cards with HIV exposure data to the well child monitoring card at birth for
institutional deliveries in order to systematically identify exposed infants at the six week
well-child care visit.
ANC: antenatal care; cART: Combination anti-retroviral therapy; CD4: Cluster of differentiation 4; HIV: Human immunodeficiency virus; PCR: Polymerase
chain reaction.
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Systems engineering process improvements are by defin-
ition iterative, entailing ongoing testing of innovations that
respond to contextually specific, modifiable barriers. Facility
staff will repeat steps one through five at the end of each
change cycle, focusing on identifying new approaches to
modify previously identified barriers, or if the first cycle
was successful, focusing on improving priority bottlenecks
identified in a repeated systems analysis.
Adaptation of the analysis tool and improvement
intervention
To ensure intervention adequacy and the implementa-
tion process, the SAIA intervention was piloted in five
facilities for six months in Sofala, Mozambique. Through
the piloting phase, the PCAT was adapted and translated
from Portuguese into French and English, a toolkit was
developed to support introduction of the intervention,
and standard operating procedures were written to guide
the implementation process and data collection procedures
for the trial.
Process for introducing the SAIA intervention
The SAIA intervention is designed to be introduced to
each study facility over a four-day period (Table 2).
On day one, trained study nurses hold a meeting with
representatives from sectors of the health facility relevantTable 2 SAIA introduction schedule
Activity Day 1 Day 1
AM PM







ANC: Antenatal care; HIV: Human immunodeficiency virus; PCAT: PMTCT cascade anto pMTCT, which may include ANC, maternity,
postpartum care, at-risk child care, laboratory, and
pharmacy staff. The specific composition depends on
the individual health facility structure. At this initial
meeting the study objectives and core components
of the intervention are introduced, a calendar of activities
for the week and across the six-month intervention period
are developed, and PCAT results populated with the
facility’s data from the most recent six months shared.
On days two and three, study nurses work with facility
staff to develop process maps for relevant services
(ANC, maternity, postpartum care, and at-risk child
care) with up to two health workers from each sector
(including the sector in-charge and a second staff
member who is knowledgeable about the health facility
and are willing to participate in the exercise). A feedback
meeting is held at the end of day three to have staff from
each sector share their process maps, prioritize which
sector to target with the initial improvement cycle,
and brainstorm potential solutions. On day four, study
nurses work with facility staff to prioritize solutions,
and develop an implementation plan that explicitly
records: the change(s) to be tested; the individual(s)
responsible for each change; metrics to assess service
improvement; a future process map to reflect the
innovation; and a follow-up visit schedule. Subsequent






alysis tool; SAIA: Systems Analysis and Improvement Approach.
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according to the schedule agreed upon by facility staff and
based on support needs.
It is expected that each change cycle will require four
to six weeks of testing to allow for sufficient time to
detect desired effects on the pMTCT cascade, but to be
short enough to allow for multiple iterations during the
six-month intervention period. After each cycle, study
staff will work with facility staff to review the original
implementation plan, describe what actually occurred
(including review of planned metrics to assess improve-
ments), discuss what worked well and why, and identify
what could be improved and how. The five-step SAIA
intervention cycle will again be repeated to review PCAT
data, update process maps, and develop the next change
cycle. It is expected that between four and six change cycles
will be implemented in each facility over the six-month
intervention period.
Study timeline
The total data collection and implementation period
is designed to cover 21 months, which includes
12 months of pre-intervention data collection, six
months of intervention implementation, and three months
of post-intervention data collection. The 12-month time-
frame for pre-intervention data collection was chosen to
generate stable baseline study outcomes despite monthly
temporal fluctuations in these measures. A total of
six months was selected for implementing the study
intervention to provide sufficient time for the intervention
to be adopted and lead to improvements, to allow for a
sufficient number of iterative system analysis and
improvement cycles to lead to sustainable performance
improvements (assuming that each cycle will last on
average four to six weeks, this timeframe will allow
for between four and six cycles per facility), and to




The three study outcomes include the proportion of
women screened for HIV during their first ANC visit; the
proportion of HIV infected women receiving antiretroviral
medications during pregnancy (either bi-prophylaxis using
AZT or combination antiretroviral therapy); and theTable 3 pMTCT outcome measures
Study measure
1. Uptake of HIV counseling and testing
2. Use of appropriate ARVs in pregnancy for prophylaxis or initiation of cART
3. Infant HIV determination
ANC: Antenatal care; ARV: Antiretroviral; AZT: Azidothymidine; cART: combination an
chain reaction.proportion of infants born to HIV-infected women
screened for HIV at six weeks postpartum (or two months
in the case of Côte d’Ivoire, following national norms)
(Table 3). These outcome measures were selected be-
cause they reflect successful progression through steps
in the pMTCT cascade, they are likely sensitive to
system-level improvements, and they represent steps that,
if changed, would meaningfully alter patterns of HIV
transmission or access to maternal and infant HIV care.
Furthermore, these measures reflect national pMTCT
protocols, and are therefore well understood and available
in all three study countries. Data will be collected over
12 months before the intervention, during the six-month
intervention, and three months after the intervention in
both intervention and comparison facilities (21 time
points and 36 measurements per time point).
All primary outcome measures are calculated as a
monthly average (continuous percentage between 0%
and 100%). Notably, outcome measures for study
measures on use of appropriate ARVs in pregnancy
for prophylaxis or initiation of cART, and infant HIV
determination, include numerators and denominators
from different time periods due to time progression
between service contacts that can be represented by
available data. For the use of appropriate ARVs in
pregnancy, the delay between the service contact in
the numerator (the number of pregnant women
receiving AZT or cART) and denominator (number
of women testing HIV positive in ANC) is estimated
to be two months. This two-month delay reflects a
mean gestational age of first ANC visit of 25 weeks,
or approximately three months before initiation of
AZT or cART. The recommended timeframe for PCR
testing of infants is on average five months after the
first ANC visit, where the majority of pregnant women
undergo HIV testing.
Covariates
Facility-level covariates include those that were found
to be associated with pMTCT performance in analyses
that are part of the wider research project that includes
the SAIA intervention trial, including patient volume,
staffing levels, availability of laboratory tests, geographic
location (urban or rural), availability of community-based
support groups, year of pMTCT initiation, and pMTCT
approach (Option B+/B/A).Numerator/Denominator
# women counseled and tested for HIV in their first ANC visit
# first ANC visits
# HIV‐infected pregnant women starting AZT prophylaxis or cART
# women testing HIV‐positive in ANC 3 months previously
# infants < 6 weeks of age receiving a PCR test
# women testing HIV‐positive in ANC 5 months previously
tiretroviral therapy; HIV: Human immunodeficiency virus; PCR: Polymerase
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Further qualitative data will be collected during the
implementation process, and at the end of the trial, to
facilitate the interpretation of the primary study results
and increase the applicability of the SAIA intervention
to other settings. The qualitative implementation process
measures were designed based on the domains of the
Consolidated Framework for Implementation Research
(CFIR) [52], and intended to provide contextual informa-
tion on factors that are important for the intervention’s
acceptability, penetration and adoption by pMTCT staff
and facility leadership, as well as factors impacting the
quality, feasibility, and sustainability of the intervention’s
application. Descriptive information will be collected on
how the SAIA intervention was introduced, facility-level
innovations that were proposed for testing, what was
actually implemented, what went well and why, and what
could be improved. Likert scale measures (scaled between
1 to 10) as well as open-ended questions will focus on
manager and staff impressions on the acceptability of the
intervention, utility of the intervention, leadership sup-
port, involvement of other agencies, intervention timing,
staff capability to implement the intervention, clarity of
roles to implement the intervention, ability of the
intervention to meet staff and patient needs, and
what the intervention fails to address.
Data sources
Primary study outcomes
Health facility registries from ANC, maternities, and
postpartum child care services are the source for monthly
performance measures pre-, during and post-intervention
at the 36 study facilities. Data extraction from registries is
performed by two trained study team members in each
facility, and compared for consistency. In cases of inconsist-
ency, data collection procedures are redone, until monthly
totals are in agreement. All project data are double-entered
into a Microsoft Access© database by each in-country study
team and sent to the Seattle-based support staff for
warehousing. Additional quality control procedures
are carried out on a monthly basis on the centralized
database to identify cases of missing data or outliers.
Covariates
Additional facility-level descriptive factors will be
collected via interviews with facility managers and
direct observation by trained study personnel using a
data collection instrument designed for the purposes of
this study. Covariates cover information on the facility
(size, geographic location, public/non-profit managed),
staffing levels and structure, service utilization, available
auxiliary services (laboratory, pharmacy, community
outreach), and other similar factors that may affect both
the adoption and effects of the intervention.Implementation process
In addition to the routinely reported administrative data,
in-country study teams will collect descriptive imple-
mentation process data on an ongoing basis using data
collection instruments designed for the purposes of
this study. A 14-item questionnaire using Likert scales
(ranging from 1 to 10) and open-ended questions was
developed to gather data relevant to the CFIR domains,
and will be applied weekly for the first four weeks of the
SAIA intervention, followed by monthly for the remaining
five months, with facility managers and a rotating group
of facility nurses. This questionnaire will be complemen-
ted by field diaries maintained daily by study teams, and
post-intervention key informant interviews with study
assistants and in-country study managers.
Analysis
The primary analysis approach to assess the impact of
the SAIA intervention will rely on paired t-tests comparing
the average outcome measures over the 12 months preced-
ing the intervention, compared with the average over the
three months directly following the intervention period,
for the three study outcomes. As a secondary analysis
approach, segmented regression analysis that controls
for baseline outcome levels and trend to compare the
monthly averages before versus after the intervention
will be carried out for all three study outcomes.
Change points will include a node at the beginning of
the intervention period to reflect the introduction of
the intervention; two additional terms will be added
to the model at the end of the six-month intervention
period to indicate the level change and trend change
post intervention. To account for a three-month lag in the
impact of the intervention, data from the first three
months post initiation of the intervention will be excluded
from analysis. Sub-analyses will be carried stratified by
country and facility size to assess subgroup effects.
Because facilities will be randomly selected and allocated
to intervention and control facilities, we do not expect to
perform adjusted analyses. However, descriptive character-
istics will be compared between intervention and compari-
son facilities using student’s t-test and chi-square tests to
assess potential imbalance between study arms, and subse-
quent analyses will consider covariates significant in bivari-
ate analysis for inclusion in the final model in a stepwise
fashion. In addition, because outcomes are reported
as a monthly summary measure at the facility level,
no additional procedures will be implemented to control
for potential intra-class correlation at the cluster (health
facility) level. Autocorrelation will be assessed using the
Durbin-Watson statistic, and adjusted for if appropriate.
Descriptive analyses will include visual inspection of
data for time trends across the study facilities, as well as
within each facility, to identify trends, assess whether
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the pMTCT cascade, and describe the sustainability of
effects associated with individual adaptations. Those
adaptations that are found to have dramatic or sustained
effects will be documented as part of identifying best prac-
tices for pMTCT improvement. Exploratory bivariate ana-
lyses using student’s t-tests and chi-square tests will be
carried out among facilities that showed large improve-
ments in study outcomes during the six-month imple-
mentation period to identify descriptive factors that may
be associated with adoption or may mediate the impact of
the SAIA intervention.
Analysis of the implementation process data will
include aggregate reporting of individual items from
the Likert scales, as well as disaggregated analysis by
study country, and by facilities found to have relatively
better success with the intervention. The constant com-
parison method will be used to describe responses to
qualitative data from open-ended questions, field diaries,
and key informant interviews.Sample size
Sample size estimates are based on the health facility as
the unit of analysis, and were calculated to detect the
change in the proportion of HIV-infected pregnant
women receiving antiretroviral medicines in pregnancy
(arguably the most important endpoint of the study).
Using program data from 2009 to 2010, we estimated a
mean pre-intervention baseline of 50%, and predicted a
mean post-intervention level of 70% for intervention
facilities (mean change score = 20%) and 50% for control
facilities (mean change score = 0%), and a standard
deviation of yearly change scores of 11%. Assuming
α = 0.05 and β = 0.80, the sample size is sufficient to
detect an 11% and a 20% difference in mean change
scores across the three countries and at the country
level, respectively (Table 4).Ethics
This study was approved by the institutional review
boards of the Ministry of Health of Côte d’Ivoire,
Kenyatta National Hospital, and the Ministry of
Health of Mozambique, and was determined to qualify for




Detectable alternative in gain scores
across intervention and control facilities
6:6 19.7%
12:12 13.2%
18:18 10.6%University of Washington. The study was registered
with ClinicalTrials.gov (NCT02023658).
Trial status
Implementation of the SAIA intervention began in January
2014 in all study countries, and is being sequentially intro-
duced in the 18 intervention facilities (six in each study
country). At the time of submission, the intervention has
been introduced in nine facilities (four in Côte d’Ivoire,
two in Kenya, and three in Mozambique).
Discussion
The SAIA study is designed as a pragmatic trial, testing an
intervention to maximize the benefits of an efficacious
intervention (pMTCT) by improving its implementation
in real world settings. Though systems engineering
techniques have been increasingly applied to health
service delivery, there is limited comparative analysis using
scientifically rigorous, prospective evaluation techniques to
support their continued use. With its rigorous design across
three sub-Saharan African countries, this randomized trial
is uniquely positioned to further our understanding of the
application of these innovative improvement techniques for
widespread use in improving health delivery in resource-
limited settings. The collection of implementation process
measures guided by a standardized, accepted framework
will provide valuable information to guide further
application and potential scale-up of the SAIA interven-
tion. Furthermore, by documenting facility-level innova-
tions tested through the SAIA intervention, the trial also
intends to identify potential strategies for further testing
and wider implementation.
The SAIA intervention has a number of potential
advantages for pMTCT services. As a flexible, user-friendly,
and low-cost approach to systems analysis and improve-
ment, the intervention can be applied to multiple contexts
and changing ARV prophylaxis or treatment guidelines.
The iterative nature of the intervention provides a
framework that can lead to sustainable, long-term service
improvements. In addition, because systems engineering
techniques have the potential to improve services and
strengthen linkages between services, the application of a
stepwise analysis and improvement approach is especially
appropriate for pMTCT services that require both pro-
gression through multiple sequential steps, and successful
linkage with non-ANC services for continued HIV care.
The rollout of the SAIA intervention to date has
generated great interest and willingness to adopt the
intervention, with only one intervention facility refusing
to participate in the trial. However, there have been
notable practical challenges thus far, including the high
level of existing research underway in the study areas,
which reduced the number of facilities eligible for
participation in the trial. Elections, conflict, floods, and
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vention in study countries. Furthermore, the initial plan to
rely on routine monthly health facility reports as the pri-
mary data source for study outcomes met with resistance
due to concerns with data quality. As a result, study
outcomes are being directly sourced from health facility
registries. An additional operational challenge has been
the high burden already placed on staff at participating
health facilities, which constrains both available time to
participate in the preparation and SAIA implementation,
as well as enthusiasm to take on additional process
improvement efforts. Finally, pMTCT guidelines have
shifted rapidly since the initial study protocol was
developed to include the initiation of cART for all
women with HIV in pregnancy independent of CD4
levels (Option B/B+). Therefore, the relative importance
of CD4 testing changed. Consequently, CD4 testing
became less relevant as a step in the PCAT and was
dropped as a primary study outcome.
Despite the challenges, the results of the SAIA interven-
tion trial are likely to be of substantial interest to policy-
makers, managers and partners working to improve the
already rolled out pMTCT services. Furthermore, the inter-
vention approach may serve as a model for other services
that, like HIV, require successful linkages across multiple
services, such as chronic non-communicable diseases that
are of growing importance, yet under-addressed in low and
middle-income countries.
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